A Promising New Strategy for Treating Triple-Negative Breast Cancer
Brigham and Women’s Hospital Research Briefs | October 9, 2024
Published in Nature - research led by Karen Cichowski’s lab in collaboration with several LSP members (including Yilin Xu, Jia-Ren Lin, Peter Sorger, and Sandro Santagata) suggests that combined treatment with AKT and EZH2 inhibitors kills TNBC cells more effectively in in vivo models. This work could provide a promising new therapeutic strategy for treating TNBC.
Latest News
May 5, 2025
WCVB Boston interviews Mark Albers on a new at-home test for Alzheimer’s risk
May 21, 2025
Featured Member: Dan Freeman discusses how industry experience helped guide him to the LSP
May 5, 2025
Immune suppression and microenvironment remodeling in precursors to ovarian cancer
March 25, 2025
Albers Lab at MGH develops new at-home test for brain health
